Medicinal Chemistry Services for Neurotherapeutics: Request for Information (RFI NS-08-024)
Funding Contact(s): Annette Carter
Funding Categories: Clinical Research
Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS) is considering developing a medicinal chemistry program
for therapy development. The goal of the program would be to develop lead compounds with sufficient potency, efficacy, and
drug-likeness to begin the preclinical pharmacology and safety (ADMET) studies required for an investigational new drug (IND)
application. The NINDS envisions awarding a contract for medicinal chemistry services.